Skip to main content

Table 2 Change from baseline in T-cell counts and laboratory results at week 48; values are medians with interquartile ranges

From: Switch from a ZDV/3TC-based regimen to a completely once daily (QD) regimen of emtricitabine/tenofovir DF fixed dose combination plus a third QD agent (SONETT)

 

Baseline

Change to week 48

p-value*

CD4+ count (cells/μl)

526 (317: 774)

30 (-72: 125)

0.23

CD8+ count (cells/μl)

907 (664: 1209)

-80 (-263: 91)

0.16

Haemoglobin (g/dl)

14.8 (14.1: 15.3)

0.8 (0.3: 1.3)

< 0.001

Fasting total cholesterol (mg/dl)

194.0 (167: 225)

-5.0 (-32: +17)

0.203

Fasting total cholesterol (mg/dl)

240.5 (222: 251)

-26.0 (-39: -4)

0.001

in patients with baseline values

   

≥ 200 mg/dl(n = 22)

   

Fasting HDL (mg/dl)

50.5 (44: 59)

52 (44: 59)

0.094

Creatinine clearance (ml/min)

114 (97: 127)

-1.3 (-13.9: 8.1)

0.20

  1. * p-value for change from baseline using Wilcoxon signed rank test